Author:
Müller Nicolle,Busch Martin,Wolf Gunter
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Alter ML, Ott IM, von Websky K, Tsuprykov O, Sharkovska Y, Krause-Relle K, Raila J, Henze A, Klein T, Hocher B (2012) DPP‑4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy. Kidney Blood Press Res 36:119–130
2. Anders HJ, Davis JM, Thurau K (2016) Nephron protection in diabetic kidney disease. N Engl J Med 375:2096–2098
3. Bundesärztekammer (BÄK), KBK, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2021) Nationale VersorgungsLeitlinie Typ-2-Diabetes – Teilpublikation der Langfassung, 2. Aufl. (Version 1)
4. Busch M, Franke S, Ruster C, Wolf G (2010) Advanced glycation end-products and the kidney. Eur J Clin Invest 40:742–755
5. Busch M, Mann J, Wolf G (2021) KDIGO guidelines on treatment of diabetes mellitus in chronic kidney disease German translation and executive summary. Nephrologe 16:169–176